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The regulation of tissue-resident memory cell development is poorly understood. In this issue of Immunity,
Laidlaw et al. (2014) demonstrate that CD4+ T cells promote development of lung-resident memory cells
by limiting T-bet expression and directing CD8+ T cells to the airway epithelium.Tissue-resident memory T (Trm) cells
comprise a distinct subset of nonmigra-
tory cells that permanently reside in or-
gans such as the skin, gut, and lung.
Trm cells have emerged as important me-
diators of local immunity (Gebhardt et al.,
2009) and, consequently, there is much
interest in elucidating the signals required
for their generation. It has been shown
that Trm cells rely on a distinct set of
regulatory cues for their development
(Mackay et al., 2013; Skon et al., 2013),
which are likely linked to their unique tis-
sue microenvironment. However, despite
recent advances, the regulation of Trm
development remains poorly defined. In
this issue of Immunity, Laidlaw et al.
(2014) provide mechanistic insights into
Trm formation and identify key check-
points required for their generation.
The study by Laidlaw and colleagues
centers on the influence of CD4+ T cell
help in CD8+ Trm cell development after
influenza virus infection of the mouse
lung. In line with other studies, tissue-
associated T cells were phenotypically
distinct from their circulating counterparts
and showed increased amounts of cardi-
nal Trm markers CD103 and CD69, as
well as the chemokine receptor CXCR3
and reduced expression of KLRG1
(Mackay et al., 2013). To explore the
requirement for CD4+ T cell help, the
authors administered antibodies to tran-
siently deplete CD4+ T cells during Trm
formation. The absence of CD4+ T cells
resulted in an impairment in the ability of
Trm to upregulate CD103, CXCR3, and to
a lesser extent, CD69. Critically, they
show that the unhelped CD8+ T cells did
not readily localize to the airway epithe-
lium, where they would otherwise have
been subjected to factors required for514 Immunity 41, October 16, 2014 ª2014 ElTrm conversion, particularly the cytokine
transforming growth factor b (TGF-b).
TGF-b is a known driver of Trm develop-
ment and, specifically, CD103 upregula-
tion (Mackayetal., 2013;ZhangandBevan
2012; Sheridan et al., 2014). It is likely that
reduced CD103 expression on unhelped
CD8+ T cells is due to insufficient exposure
to TGF-b signals rather than an inability
to respond to TGF-b per se, because
helped and unhelped cells could respond
equally well to this cytokine in vitro. The
generation of lung-resident CD103+ CD8+
Trm cells was dependent on CD4+ T cell-
derived interferon-g (IFN-g), because
IFN-g knockout animals phenocopied the
defective Trm cell development seen in
the absence of CD4+ T cell help. IFN-g
was shown to exert its effects in a cell-
extrinsic manner, as CD8+ T cells lacking
the cytokine receptor displayed no defect
in the Trm cell phenotype.
Given that entry of CD4+ T cells into the
lung preceded that of the CD8+ T cells
following infection, the authors specu-
lated that the helper cells condition the
local microenvironment via IFN-g secre-
tion to promote optimal CD8+ T cell entry.
CD4+ T cells have been shown to exert
this type of pioneering effect during
T cell responses in the vaginal mucosa
by a mechanism involving IFN-g-medi-
ated induction of CXCR3 ligands required
for CD8+ T cell infiltration of the tissue
(Nakanishi et al., 2009). It is known that
CXCR3 is required for CD8+ T cell locali-
zation to the lung airways (Slu¨tter et al.,
2013), which is consistent with such a
proposed mechanism. Importantly, CD4+
T cell help was only required during the
early phase of Trm cell development,
with elimination of CD4+ T cells having lit-
tle impact after Trm cell formation hadsevier Inc.been established. The latter is consistent
with earlier studies showing that Trm cell
precursors are present in the circulation
only transiently after infection (Masopust
et al., 2010), as well as the suggestion
by Laidlaw et al. that the CD4+ T cells
act, in part, by getting CD8+ T cells to
the correct location to undergo a TGF-
b-driven process of Trm cell maturation.
So howdoesCD4+ T cell pioneering and
appropriate Trm cell localization affect
events that are downstream of optimal
TGF-b encounter? Laidlaw et al. (2014)
show that CD4+ T cell help is also required
to downregulate T-bet, and this decrease
was necessary for optimum Trm cell
development. Trm cells have lower
amounts of T-bet compared to their coun-
terparts in the circulation, and this reduc-
tion appears pivotal, since Trm formation
is attenuated following forced expression
of this transcription factor. T-bet is likely
acting as a repressor and this transcription
factor is known to bind to regulatory
regions of the key Trm cell gene, Cd103.
Because TGF-b has been shown to down-
regulate T-bet expression, the authors
speculate that the high T-bet expression
seen in the unhelped CD8+ T cells follows
directly from the defective localization of
the unhelped T cells within the lung.
Overall, Laidlaw et al. (2014) suggest a
linked series of events associated with
CD4+ T cell help, which together drive op-
timum Trm cell development (Figure 1).
First, CD4+ T cells promote proper locali-
zation of the Trm cell precursors to the
airway epithelium via IFN-g, which in turn
facilitates full access to theTGF-b required
for Trm cell development. TGF-b then
promotes T-bet downregulation, which
releases the Cd103 gene locus from
transcriptional repression. Some of the
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Figure 1. CD4+ T Cells ‘‘Help’’ the Formation of Lung-Resident CD8+ Trm Cells
CD4+ T cells secrete IFN-g, which conditions the tissue microenvironment and directs the localization of
CD8+ T cells to the airway epithelia where they are subjected to Trm-promoting cytokines such as TGF-b
(left). Helped CD8+ T cells express high amounts of CD103, CD69, CXCR3, and low levels of T-bet. In
the absence of CD4+ T cell help, CD8+ T cells do not efficiently enter the airway epithelia. Unhelped CD8+
T cells show impaired expression of CD103, CXCR3, and CD69 and express high amounts of T-bet (right).
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the cytokine TGF-b and the transcription
factor T-bet, are known to have a broad
impact on T cell maturation and so might
have other effects on Trm cell formation
or survival. Nonetheless, the study by
Laidlaw and colleagues clearly highlights
that T-bet downregulation affects Trm
cell development in the lung and it will be
interesting to determine whether this is
also the case for Trm cells in other tissues.
To underscore the importance of CD4+
T cell help in Trm cell formation, Laidlaw
et al. (2014) show that unhelped CD8+
T cells were also impaired in their ability
to mediate protection against hetero-
subtypic influenza virus infection. In the
absence of CD4+ T cells, mice exhibited
both a defect in CD8+ Trm cells in thelung and decreased CD8+ T cell recruit-
ment from the blood. This compromised
recruitment could be ascribed to the
underlying defect in lung Trm cells,
which are otherwise capable of recruit-
ing cells from the circulation, much like
what was shown for Trm cells in the
female reproductive tract (Schenkel et al.,
2013). Regardless, the data indicate a
role for both resident and circulating
CD8+ T cells in mediating optimal antiviral
protection, although the relative con-
tributions of the respective subsets to pro-
tective immunity remain to be determined.
Altogether, Laidlaw and colleagues
offer mechanistic insight into Trm cell
development, which represents an essen-
tial step toward enhancing the generation
of these cells for therapeutic purposes.Immunity 41The study emphasizes the key role of
tissue microenvironment in promoting
Trm cell development, and it is likely that
location-specific cues regulate many
other properties of Trm cells. Future in-
vestigations will be vital to establish other
factors that drive this cell lineage.
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Because of its lethality, the Ebola virus often appears to be an invincible adversary. InNature, Qiu et al. (2014)
recently described the complete protection of nonhuman primates from deadly Ebola virus disease, even
when treatment was begun as late as 5 days after infection.By far the most widespread and deadly
Ebola virus emergence on record, the
2014 outbreak in West Africa continuesto expand at an exponential rate. Recent
projections suggest that many tens of
thousands of people are at risk of con-tracting this deadly disease. The grim cir-
cumstances surrounding the ongoing
epidemic highlight the lack of approved, October 16, 2014 ª2014 Elsevier Inc. 515
